Life is a pattern: Vascular assembly within the embryo

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 6, 2012, Pages 2269-2288

  Heinke, Jennifer ^a   Patterson, Cam ^b   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenic signaling; Angiopoetins; Embryogenesis; Endothelium; Review; TGF beta; Vascular development; VEGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; COLLAGEN FIBER; EPHRIN B2; FIBROBLAST GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; MICRORNA; PLATELET DERIVED GROWTH FACTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DNA BINDING; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION; HEMANGIOBLAST; INTRACELLULAR SIGNALING; LIFE; MESODERM; MOLECULE; PHENOTYPE; PROTEIN BINDING; VASCULARIZATION; YOLK SAC; ANIMAL; BLOOD VESSEL; HUMAN; MORPHOGENESIS; PRENATAL DEVELOPMENT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD VESSELS; BODY PATTERNING; EMBRYONIC DEVELOPMENT; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 84860872919     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (239)

1. Carmeliet, P. & R. K. Jain: Angiogenesis in cancer and other diseases. Nature, 407, 249-57 (2000))
2. Fraisl, P., M. Mazzone, T. Schmidt & P. Carmeliet: Regulation of angiogenesis by oxygen and metabolism. Dev Cell, 16, 167-79 (2009))
3. Brown, A. & J. Barnes: William Harvey (1578-1657) and Marcello Malpighi (1628-1694): linked in blood, paralleled in life. Adler Mus Bull, 20, 14-23 (1994))
4. Aird, W. C.: Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res, 100, 158-73 (2007)) (Pubitemid 46208717)
5. Aird, W. C.: Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res, 100, 174-90 (2007)) (Pubitemid 46208718)
6. Carmeliet, P.: Angiogenesis in health and disease. Nat Med, 9, 653-60 (2003)) (Pubitemid 36749213)
7. Adams, R. H. & K. Alitalo: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol, 8, 464-78 (2007)) (Pubitemid 46823443)
8. Risau, W.: Mechanisms of angiogenesis. Nature, 386, 671-4 (1997)) (Pubitemid 27193480)
9. Aird, W. C.: Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res, 98, 159-62 (2006))
10. Semenza, G. L.: Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem, 102, 840-7 (2007)) (Pubitemid 350036924)
11. Coultas, L., K. Chawengsaksophak & J. Rossant: Endothelial cells and VEGF in vascular development. Nature, 438, 937-45 (2005)) (Pubitemid 43093959)
12. Rossant, J. & L. Howard: Signaling pathways in vascular development. Annu Rev Cell Dev Biol, 18, 541-73 (2002)) (Pubitemid 35387361)
13. Adelman, D. M., M. Gertsenstein, A. Nagy, M. C. Simon & E. Maltepe: Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev, 14, 3191-203 (2000)) (Pubitemid 32015136)
14. Ramirez-Bergeron, D. L., A. Runge, K. D. Dahl, H. J. Fehling, G. Keller & M. C. Simon: Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development, 131, 4623-34 (2004)) (Pubitemid 39409701)
15. Lucitti, J. L., E. A. Jones, C. Huang, J. Chen, S. E. Fraser & M. E. Dickinson: Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development, 134, 3317-26 (2007)) (Pubitemid 350018432)
16. Jones, E. A., M. H. Baron, S. E. Fraser & M. E. Dickinson: Measuring hemodynamic changes during mammalian development. Am J Physiol Heart Circ Physiol, 287, H1561-9 (2004)) (Pubitemid 39313260)
17. Lawson, N. D., N. Scheer, V. N. Pham, C. H. Kim, A. B. Chitnis, J. A. Campos-Ortega & B. M. Weinstein: Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development, 128, 3675-83 (2001)) (Pubitemid 32998917)
18. Lawson, N. D. & B. M. Weinstein: In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol, 248, 307-18 (2002)) (Pubitemid 35002091)
19. Isogai, S., N. D. Lawson, S. Torrealday, M. Horiguchi & B. M. Weinstein: Angiogenic network formation in the developing vertebrate trunk. Development, 130, 5281-90 (2003)) (Pubitemid 37369685)
20. Risau, W. & I. Flamme: Vasculogenesis. Annu Rev Cell Dev Biol, 11, 73-91 (1995)) (Pubitemid 26019602)
21. Ferkowicz, M. J. & M. C. Yoder: Blood island formation: longstanding observations and modern interpretations. Exp Hematol, 33, 1041-7 (2005))
22. Drake, C. J. & P. A. Fleming: Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood, 95, 1671-9 (2000))
23. Argraves, W. S. & C. J. Drake: Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. Anat Rec A Discov Mol Cell Evol Biol, 286, 875-84 (2005)) (Pubitemid 41434211)
24. Downs, K. M., S. Gifford, M. Blahnik & R. L. Gardner: Vascularization in the murine allantois occurs by vasculogenesis without accompanying erythropoiesis. Development, 125, 4507-20 (1998)) (Pubitemid 28564294)
25. Caprioli, A., T. Jaffredo, R. Gautier, C. Dubourg & F. Dieterlen-Lievre: Blood-borne seeding by hematopoietic and endothelial precursors from the allantois. Proc Natl Acad Sci U S A, 95, 1641-6 (1998))
26. Yamaguchi, T. P., D. J. Dumont, R. A. Conlon, M. L. Breitman & J. Rossant: flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development, 118, 489-98 (1993)) (Pubitemid 23214035)
27. Huber, T. L., V. Kouskoff, H. J. Fehling, J. Palis & G. Keller: Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature, 432, 625-30 (2004)) (Pubitemid 39626269)
28. Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman & A. C. Schuh: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 376, 62-6 (1995))
29. Risau, W., H. Sariola, H. G. Zerwes, J. Sasse, P. Ekblom, R. Kemler & T. Doetschman: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development, 102, 471-8 (1988)) (Pubitemid 18084930)
30. Sabin, F. R.: Preliminary note on the differentiation of angioblasts and the method by which they produce bloodvessels, blood plasma, and red blood-cells as seen in the living chick. Anat Rec 13, 19-204 (1917))
31. Murray, P. D. F.: The Development in vitro of the Blood of the Early Chick Embryo. Proceedings of the Royal Society of London. Series B, Biological Science, 111, 497-521 (1932))
32. Jin, S. W. & C. Patterson: The Opening Act. Vasculogenesis and the Origins of Circulation. Arterioscler Thromb Vasc Biol (2008))
33. Shalaby, F., J. Ho, W. L. Stanford, K. D. Fischer, A. C. Schuh, L. Schwartz, A. Bernstein & J. Rossant: A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell, 89, 981-90 (1997)) (Pubitemid 27513524)
34. Choi, K., M. Kennedy, A. Kazarov, J. C. Papadimitriou & G. Keller: A common precursor for hematopoietic and endothelial cells. Development, 125, 725-32 (1998)) (Pubitemid 28108096)
35. Vogeli, K. M., S. W. Jin, G. R. Martin & D. Y. Stainier: A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula. Nature, 443, 337-9 (2006)) (Pubitemid 44435152)
36. Jaffredo, T., R. Gautier, A. Eichmann & F. Dieterlen-Lievre: Intraaortic hemopoietic cells are derived from endothelial cells during ontogeny. Development, 125, 4575-83 (1998)) (Pubitemid 28564300)
37. Nishikawa, S. I., S. Nishikawa, H. Kawamoto, H. Yoshida, M. Kizumoto, H. Kataoka & Y. Katsura: In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity, 8, 761-9 (1998)) (Pubitemid 28294523)
38. North, T. E., M. F. de Bruijn, T. Stacy, L. Talebian, E. Lind, C. Robin, M. Binder, E. Dzierzak & N. A. Speck: Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity, 16, 661-72 (2002)) (Pubitemid 34626687)
39. Lancrin, C., P. Sroczynska, C. Stephenson, T. Allen, V. Kouskoff & G. Lacaud: The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature (2009))
40. Eilken, H. M., S. Nishikawa & T. Schroeder: Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature, 457, 896-900 (2009))
41. Sadlon, T. J., I. D. Lewis & R. J. D'Andrea: BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells, 22, 457-74 (2004)) (Pubitemid 39014563)
42. Ishii, Y., J. Langberg, K. Rosborough & T. Mikawa: Endothelial cell lineages of the heart. Cell Tissue Res, 335, 67-73 (2009))
43. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand & J. Holash: Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-8 (2000))
44. Carmeliet, P.: Mechanisms of angiogenesis and arteriogenesis. Nat Med, 6, 389-95 (2000)) (Pubitemid 30208155)
45. Burri, P. H., R. Hlushchuk & V. Djonov: Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn, 231, 474-88 (2004)) (Pubitemid 39410882)
46. Patan, S.: Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol, 50, 1-15 (2000)) (Pubitemid 32166287)
47. Djonov, V., O. Baum & P. H. Burri: Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res, 314, 107-17 (2003)) (Pubitemid 37409917)
48. Kurz, H., P. H. Burri & V. G. Djonov: Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci, 18, 65-70 (2003)) (Pubitemid 36523784)
49. Davis, G. E. & D. R. Senger: Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res, 97, 1093-107 (2005))
50. Gerhardt, H., M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, C. Mitchell, K. Alitalo, D. Shima & C. Betsholtz: VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol, 161, 1163-77 (2003)) (Pubitemid 36870177)
51. ten Dijke, P. & H. M. Arthur: Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol, 8, 857-69 (2007)) (Pubitemid 47622560)
52. Cao, L., X. Jiao, D. S. Zuzga, Y. Liu, D. M. Fong, D. Young & M. J. During: VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet, 36, 827-35 (2004)) (Pubitemid 39014099)
53. Jin, K., Y. Zhu, Y. Sun, X. O. Mao, L. Xie & D. A. Greenberg: Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A, 99, 11946-50 (2002))
54. Tam, B. Y., K. Wei, J. S. Rudge, J. Hoffman, J. Holash, S. K. Park, J. Yuan, C. Hefner, C. Chartier, J. S. Lee, S. Jiang, N. R. Nayak, F. A. Kuypers, L. Ma, U. Sundram, G. Wu, J. A. Garcia, S. L. Schrier, J. J. Maher, R. S. Johnson, G. D. Yancopoulos, R. C. Mulligan & C. J. Kuo: VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med, 12, 793-800 (2006)) (Pubitemid 44050069)
55. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan & M. W. Moore: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-42 (1996)) (Pubitemid 26102720)
56. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau & A. Nagy: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-9 (1996)) (Pubitemid 26102719)
57. Fong, G. H., J. Rossant, M. Gertsenstein & M. L. Breitman: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70 (1995))
58. Dumont, D. J., L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breitman & K. Alitalo: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science, 282, 946-9 (1998)) (Pubitemid 28507528)
59. Takashima, S., M. Kitakaze, M. Asakura, H. Asanuma, S. Sanada, F. Tashiro, H. Niwa, J. Miyazaki Ji, S. Hirota, Y. Kitamura, T. Kitsukawa, H. Fujisawa, M. Klagsbrun & M. Hori: Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A, 99, 3657-62 (2002)) (Pubitemid 34252162)
60. Kendall, R. L. & K. A. Thomas: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A, 90, 10705-9 (1993))
61. Kearney, J. B., C. A. Ambler, K. A. Monaco, N. Johnson, R. G. Rapoport & V. L. Bautch: Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood, 99, 2397-407 (2002)) (Pubitemid 34525425)
62. Ferrara, N., H. P. Gerber & J. LeCouter: The biology of VEGF and its receptors. Nat Med, 9, 669-76 (2003)) (Pubitemid 36749215)
63. Hiratsuka, S., K. Nakao, K. Nakamura, M. Katsuki, Y. Maru & M. Shibuya: Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol, 25, 346-54 (2005)) (Pubitemid 40039824)
64. Fong, G. H., L. Zhang, D. M. Bryce & J. Peng: Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development, 126, 3015-25 (1999)) (Pubitemid 29355693)
65. Autiero, M., J. Waltenberger, D. Communi, A. Kranz, L. Moons, D. Lambrechts, J. Kroll, S. Plaisance, M. De Mol, F. Bono, S. Kliche, G. Fellbrich, K. Ballmer-Hofer, D. Maglione, U. Mayr-Beyrle, M. Dewerchin, S. Dombrowski, D. Stanimirovic, P. Van Hummelen, C. Dehio, D. J. Hicklin, G. Persico, J. M. Herbert, D. Communi, M. Shibuya, D. Collen, E. M. Conway & P. Carmeliet: Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med, 9, 936-43 (2003)) (Pubitemid 36889938)
66. Olsson, A. K., A. Dimberg, J. Kreuger & L. Claesson-Welsh: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol, 7, 359-71 (2006))
67. Carmeliet, P., M. G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oosthuyse, M. Dewerchin, A. Zanetti, A. Angellilo, V. Mattot, D. Nuyens, E. Lutgens, F. Clotman, M. C. de Ruiter, A. Gittenberger-de Groot, R. Poelmann, F. Lupu, J. M. Herbert, D. Collen & E. Dejana: Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell, 98, 147-57 (1999)) (Pubitemid 29344903)
68. Grazia Lampugnani, M., A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, A. Cattelino, R. Kemler, T. O. Daniel & E. Dejana: Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol, 161, 793-804 (2003)) (Pubitemid 36648762)
69. Shibuya, M.: Vascular endothelial growth factordependent and -independent regulation of angiogenesis. BMB Rep, 41, 278-86 (2008)) (Pubitemid 351656921)
70. Karkkainen, M. J., T. Makinen & K. Alitalo: Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol, 4, E2-5 (2002)) (Pubitemid 34071967)
71. Dumont, D. J., G. Gradwohl, G. H. Fong, M. C. Puri, M. Gertsenstein, A. Auerbach & M. L. Breitman: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev, 8, 1897-909 (1994)) (Pubitemid 24273890)
72. Sato, T. N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau & Y. Qin: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, 376, 70-4 (1995))
73. Suri, C., P. F. Jones, S. Patan, S. Bartunkova, P. C. Maisonpierre, S. Davis, T. N. Sato & G. D. Yancopoulos: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87, 1171-80 (1996)) (Pubitemid 27010101)
74. Puri, M. C., J. Rossant, K. Alitalo, A. Bernstein & J. Partanen: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. Embo J, 14, 5884-91 (1995))
75. Gale, N. W., G. Thurston, S. F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C. Witte, M. H. Witte, D. Jackson, C. Suri, P. A. Campochiaro, S. J. Wiegand & G. D. Yancopoulos: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell, 3, 411-23 (2002))
76. Pitera, J. E., A. S. Woolf, N. W. Gale, G. D. Yancopoulos & H. T. Yuan: Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice. Am J Pathol, 165, 1895-906 (2004)) (Pubitemid 39578369)
77. Hackett, S. F., H. Ozaki, R. W. Strauss, K. Wahlin, C. Suri, P. Maisonpierre, G. Yancopoulos & P. A. Campochiaro: Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol, 184, 275-84 (2000)) (Pubitemid 30625490)
78. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato & G. D. Yancopoulos: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60 (1997)) (Pubitemid 27450643)
79. Reiss, Y., J. Droste, M. Heil, S. Tribulova, M. H. Schmidt, W. Schaper, D. J. Dumont & K. H. Plate: Angiopoietin-2 impairs revascularization after limb ischemia. Circ Res, 101, 88-96 (2007)) (Pubitemid 47094627)
80. Augustin, H. G., G. Y. Koh, G. Thurston & K. Alitalo: Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol, 10, 165-77 (2009))
81. Fiedler, U., T. Krissl, S. Koidl, C. Weiss, T. Koblizek, U. Deutsch, G. Martiny-Baron, D. Marme & H. G. Augustin: Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem, 278, 1721-7 (2003))
82. Macdonald, P. R., P. Progias, B. Ciani, S. Patel, U. Mayer, M. O. Steinmetz & R. A. Kammerer: Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope. J Biol Chem, 281, 28408-14 (2006))
83. Marron, M. B., D. P. Hughes, M. D. Edge, C. L. Forder & N. P. Brindle: Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem, 275, 39741-6 (2000))
84. Tsiamis, A. C., P. N. Morris, M. B. Marron & N. P. Brindle: Vascular endothelial growth factor modulates the Tie- 2:Tie-1 receptor complex. Microvasc Res, 63, 149-58 (2002)) (Pubitemid 34971631)
85. Marron, M. B., H. Singh, T. A. Tahir, J. Kavumkal, H. Z. Kim, G. Y. Koh & N. P. Brindle: Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem, 282, 30509-17 (2007))
86. Jones, N., K. Iljin, D. J. Dumont & K. Alitalo: Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol, 2, 257-67 (2001)) (Pubitemid 33676968)
87. Fiedler, U., Y. Reiss, M. Scharpfenecker, V. Grunow, S. Koidl, G. Thurston, N. W. Gale, M. Witzenrath, S. Rosseau, N. Suttorp, A. Sobke, M. Herrmann, K. T. Preissner, P. Vajkoczy & H. G. Augustin: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med, 12, 235-9 (2006)) (Pubitemid 43214752)
88. Saharinen, P., L. Eklund, J. Miettinen, R. Wirkkala, A. Anisimov, M. Winderlich, A. Nottebaum, D. Vestweber, U. Deutsch, G. Y. Koh, B. R. Olsen & K. Alitalo: Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol, 10, 527-37 (2008)) (Pubitemid 351627372)
89. Fukuhara, S., K. Sako, T. Minami, K. Noda, H. Z. Kim, T. Kodama, M. Shibuya, N. Takakura, G. Y. Koh & N. Mochizuki: Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol, 10, 513-26 (2008)) (Pubitemid 351627371)
90. Scharpfenecker, M., U. Fiedler, Y. Reiss & H. G. Augustin: The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci, 118, 771-80 (2005)) (Pubitemid 40372585)
91. Eklund, L. & B. R. Olsen: Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res, 312, 630-41 (2006)) (Pubitemid 43290339)
92. Cao, Y., R. Cao & E. M. Hedlund: R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med, 86, 785-9 (2008))
93. Soriano, P.: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev, 8, 1888-96 (1994))
94. Leveen, P., M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson & C. Betsholtz: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev, 8, 1875-87 (1994)) (Pubitemid 24273888)
95. Lindahl, P., B. R. Johansson, P. Leveen & C. Betsholtz: Pericyte loss and microaneurysm formation in PDGF-Bdeficient mice. Science, 277, 242-5 (1997)) (Pubitemid 27446080)
96. Hellstrom, M., H. Gerhardt, M. Kalen, X. Li, U. Eriksson, H. Wolburg & C. Betsholtz: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol, 153, 543-53 (2001)) (Pubitemid 34280141)
97. Chen, S. & R. J. Lechleider: Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line. Circ Res, 94, 1195-202 (2004)) (Pubitemid 38656406)
98. Armulik, A., A. Abramsson & C. Betsholtz: Endothelial/pericyte interactions. Circ Res, 97, 512-23 (2005)) (Pubitemid 41361741)
99. Goumans, M. J., Z. Liu & P. ten Dijke: TGF-beta signaling in vascular biology and dysfunction. Cell Res, 19, 116-27 (2009))
100. Dickson, M. C., J. S. Martin, F. M. Cousins, A. B. Kulkarni, S. Karlsson & R. J. Akhurst: Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development, 121, 1845-54 (1995))
101. Oh, S. P., T. Seki, K. A. Goss, T. Imamura, Y. Yi, P. K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim & E. Li: Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A, 97, 2626-31 (2000)) (Pubitemid 30159221)
102. Deckers, M. M., R. L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van Der Bent, S. E. Papapoulos & C. W. Lowik: Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology, 143, 1545-53 (2002)) (Pubitemid 34274386)
103. Park, C., I. Afrikanova, Y. S. Chung, W. J. Zhang, E. Arentson, G. Fong Gh, A. Rosendahl & K. Choi: A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development, 131, 2749-62 (2004)) (Pubitemid 38877906)
104. Little, S. C. & M. C. Mullins: Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis. Nat Cell Biol (2009))
105. Smadja, D. M., I. Bieche, J. S. Silvestre, S. Germain, A. Cornet, I. Laurendeau, J. P. Duong-Van-Huyen, J. Emmerich, M. Vidaud, M. Aiach & P. Gaussem: Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol, 28, 2137-43 (2008))
106. Winnier, G., M. Blessing, P. A. Labosky & B. L. Hogan: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev, 9, 2105-16 (1995))
107. Mishina, Y., A. Suzuki, N. Ueno & R. R. Behringer: Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev, 9, 3027-37 (1995)) (Pubitemid 26018138)
108. Gu, Z., E. M. Reynolds, J. Song, H. Lei, A. Feijen, L. Yu, W. He, D. T. MacLaughlin, J. van den Eijnden-van Raaij, P. K. Donahoe & E. Li: The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development, 126, 2551-61 (1999)) (Pubitemid 29299023)
109. Beppu, H., M. Kawabata, T. Hamamoto, A. Chytil, O. Minowa, T. Noda & K. Miyazono: BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol, 221, 249-58 (2000)) (Pubitemid 30253588)
110. Tremblay, K. D., N. R. Dunn & E. J. Robertson: Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development, 128, 3609-21 (2001)) (Pubitemid 32962727)
111. Lechleider, R. J., J. L. Ryan, L. Garrett, C. Eng, C. Deng, A. Wynshaw-Boris & A. B. Roberts: Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol, 240, 157-67 (2001)) (Pubitemid 33141115)
112. Chang, H., D. Huylebroeck, K. Verschueren, Q. Guo, M. M. Matzuk & A. Zwijsen: Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development, 126, 1631-42 (1999)) (Pubitemid 29204328)
113. Yang, X., L. H. Castilla, X. Xu, C. Li, J. Gotay, M. Weinstein, P. P. Liu & C. X. Deng: Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development, 126, 1571-80 (1999)) (Pubitemid 29204322)
114. Lan, Y., B. Liu, H. Yao, F. Li, T. Weng, G. Yang, W. Li, X. Cheng, N. Mao & X. Yang: Essential role of endothelial Smad4 in vascular remodeling and integrity. Mol Cell Biol, 27, 7683-92 (2007)) (Pubitemid 350033673)
115. Moser, M., O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, V. L. Bautch, F. L. Conlon & C. Patterson: BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol, 23, 5664-79 (2003)) (Pubitemid 36951331)
116. Heinke, J., L. Wehofsits, Q. Zhou, C. Zoeller, K. M. Baar, T. Helbing, A. Laib, H. Augustin, C. Bode, C. Patterson & M. Moser: BMPER Is an Endothelial Cell Regulator and Controls Bone Morphogenetic Protein-4- Dependent Angiogenesis. Circ Res (2008))
117. Moser, M., Q. Yu, C. Bode, J. W. Xiong & C. Patterson: BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish. J Mol Cell Cardiol, 43, 243-53 (2007)) (Pubitemid 47304444)
118. Carmeliet, P. & M. Tessier-Lavigne: Common mechanisms of nerve and blood vessel wiring. Nature, 436, 193-200 (2005)) (Pubitemid 41021263)
119. Eichmann, A., T. Makinen & K. Alitalo: Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev, 19, 1013-21 (2005)) (Pubitemid 40632446)
120. Flanagan, J. G. & P. Vanderhaeghen: The ephrins and Eph receptors in neural development. Annu Rev Neurosci, 21, 309-45 (1998)) (Pubitemid 28150666)
121. Wang, H. U., Z. F. Chen & D. J. Anderson: Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell, 93, 741-53 (1998)) (Pubitemid 28257581)
122. Gerety, S. S., H. U. Wang, Z. F. Chen & D. J. Anderson: Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell, 4, 403-14 (1999)) (Pubitemid 29499793)
123. Suchting, S., C. Freitas, F. le Noble, R. Benedito, C. Breant, A. Duarte & A. Eichmann: The Notch ligand Deltalike 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A, 104, 3225-30 (2007)) (Pubitemid 46364141)
124. Hellstrom, M., L. K. Phng, J. J. Hofmann, E. Wallgard, L. Coultas, P. Lindblom, J. Alva, A. K. Nilsson, L. Karlsson, N. Gaiano, K. Yoon, J. Rossant, M. L. Iruela-Arispe, M. Kalen, H. Gerhardt & C. Betsholtz: DLL4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 445, 776-80 (2007)) (Pubitemid 46279716)
125. Gitler, A. D., M. M. Lu & J. A. Epstein: PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell, 7, 107-16 (2004)) (Pubitemid 39172692)
126. Torres-Vazquez, J., A. D. Gitler, S. D. Fraser, J. D. Berk, N. P. Van, M. C. Fishman, S. Childs, J. A. Epstein & B. M. Weinstein: Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell, 7, 117-23 (2004)) (Pubitemid 39172693)
127. Wilson, B. D., M. Ii, K. W. Park, A. Suli, L. K. Sorensen, F. Larrieu-Lahargue, L. D. Urness, W. Suh, J. Asai, G. A. Kock, T. Thorne, M. Silver, K. R. Thomas, C. B. Chien, D. W. Losordo & D. Y. Li: Netrins promote developmental and therapeutic angiogenesis. Science, 313, 640-4 (2006)) (Pubitemid 44201136)
128. Park, K. W., C. M. Morrison, L. K. Sorensen, C. A. Jones, Y. Rao, C. B. Chien, J. Y. Wu, L. D. Urness & D. Y. Li: Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol, 261, 251-67 (2003)) (Pubitemid 36993830)
129. Bedell, V. M., S. Y. Yeo, K. W. Park, J. Chung, P. Seth, V. Shivalingappa, J. Zhao, T. Obara, V. P. Sukhatme, I. A. Drummond, D. Y. Li & R. Ramchandran: roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci U S A, 102, 6373-8 (2005))
130. Sainson, R. C., J. Aoto, M. N. Nakatsu, M. Holderfield, E. Conn, E. Koller & C. C. Hughes: Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. Faseb J, 19, 1027-9 (2005))
131. Lobov, I. B., R. A. Renard, N. Papadopoulos, N. W. Gale, G. Thurston, G. D. Yancopoulos & S. J. Wiegand: Delta-like ligand 4 (DLL4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A, 104, 3219-24 (2007)) (Pubitemid 46364140)
132. Soker, S., S. Takashima, H. Q. Miao, G. Neufeld & M. Klagsbrun: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92, 735-45 (1998)) (Pubitemid 28155313)
133. Gluzman-Poltorak, Z., T. Cohen, Y. Herzog & G. Neufeld: Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 (corrected). J Biol Chem, 275, 18040-5 (2000))
134. Kawamura, H., X. Li, K. Goishi, L. A. van Meeteren, L. Jakobsson, S. Cebe-Suarez, A. Shimizu, D. Edholm, K. Ballmer-Hofer, L. Kjellen, M. Klagsbrun & L. Claesson-Welsh: Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood, 112, 3638-49 (2008))
135. Sawamiphak, S., S. Seidel, C. L. Essmann, G. A. Wilkinson, M. E. Pitulescu, T. Acker & A. Acker-Palmer: Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature, 465, 487-91 (2010))
136. Wang, Y., M. Nakayama, M. E. Pitulescu, T. S. Schmidt, M. L. Bochenek, A. Sakakibara, S. Adams, A. Davy, U. Deutsch, U. Luthi, A. Barberis, L. E. Benjamin, T. Makinen, C. D. Nobes & R. H. Adams: Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature, 465, 483-6 (2010))
137. De Val, S. & B. L. Black: Transcriptional control of endothelial cell development. Dev Cell, 16, 180-95 (2009))
138. De Val, S., N. C. Chi, S. M. Meadows, S. Minovitsky, J. P. Anderson, I. S. Harris, M. L. Ehlers, P. Agarwal, A. Visel, S. M. Xu, L. A. Pennacchio, I. Dubchak, P. A. Krieg, D. Y. Stainier & B. L. Black: Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell, 135, 1053-64 (2008))
139. Oettgen, P.: Transcriptional regulation of vascular development. Circ Res, 89, 380-8 (2001)) (Pubitemid 34132653)
140. Papanicolaou, K. N., Y. Izumiya & K. Walsh: Forkhead transcription factors and cardiovascular biology. Circ Res, 102, 16-31 (2008))
141. Gorski, D. H. & K. Walsh: The role of homeobox genes in vascular remodeling and angiogenesis. Circ Res, 87, 865-72 (2000))
142. Atkins, G. B. & M. K. Jain: Role of Kruppel-like transcription factors in endothelial biology. Circ Res, 100, 1686-95 (2007)) (Pubitemid 46987860)
143. Bernat, J. A., G. E. Crawford, A. Y. Ogurtsov, F. S. Collins, D. Ginsburg & A. S. Kondrashov: Distant conserved sequences flanking endothelial-specific promoters contain tissue-specific DNase-hypersensitive sites and over-represented motifs. Hum Mol Genet, 15, 2098-105 (2006)) (Pubitemid 43923399)
144. Bloor, A. J., M. J. Sanchez, A. R. Green & B. Gottgens: The role of the stem cell leukemia (SCL) gene in hematopoietic and endothelial lineage specification. J Hematother Stem Cell Res, 11, 195-206 (2002)) (Pubitemid 34309515)
145. Lugus, J. J., Y. S. Chung, J. C. Mills, S. I. Kim, J. Grass, M. Kyba, J. M. Doherty, E. H. Bresnick & K. Choi: GATA2 functions at multiple steps in hemangioblast development and differentiation. Development, 134, 393-405 (2007))
146. Kappel, A., T. M. Schlaeger, I. Flamme, S. H. Orkin, W. Risau & G. Breier: Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood, 96, 3078-85 (2000))
147. Choi, J., L. Dong, J. Ahn, D. Dao, M. Hammerschmidt & J. N. Chen: FoxH1 negatively modulates flk1 gene expression and vascular formation in zebrafish. Dev Biol, 304, 735-44 (2007)) (Pubitemid 46527576)
148. Kappel, A., V. Ronicke, A. Damert, I. Flamme, W. Risau & G. Breier: Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood, 93, 4284-92 (1999)) (Pubitemid 29279271)
149. Bhattacharya, R., S. Senbanerjee, Z. Lin, S. Mir, A. Hamik, P. Wang, P. Mukherjee, D. Mukhopadhyay & M. K. Jain: Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem, 280, 28848-51 (2005))
150. Wu, Y., M. Moser, V. L. Bautch & C. Patterson: HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells. Mol Cell Biol, 23, 5680-91 (2003)) (Pubitemid 36951332)
151. Harris, A. L.: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer, 2, 38-47 (2002)) (Pubitemid 37328806)
152. Hosaka, T., W. H. Biggs, 3rd, D. Tieu, A. D. Boyer, N. M. Varki, W. K. Cavenee & K. C. Arden: Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A, 101, 2975-80 (2004)) (Pubitemid 38327721)
153. Potente, M., C. Urbich, K. Sasaki, W. K. Hofmann, C. Heeschen, A. Aicher, R. Kollipara, R. A. DePinho, A. M. Zeiher & S. Dimmeler: Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest, 115, 2382-92 (2005)) (Pubitemid 41266200)
154. Paik, J. H., R. Kollipara, G. Chu, H. Ji, Y. Xiao, Z. Ding, L. Miao, Z. Tothova, J. W. Horner, D. R. Carrasco, S. Jiang, D. G. Gilliland, L. Chin, W. H. Wong, D. H. Castrillon & R. A. DePinho: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 128, 309-23 (2007)) (Pubitemid 46123514)
155. Bruhl, T., C. Urbich, D. Aicher, A. Acker-Palmer, A. M. Zeiher & S. Dimmeler: Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res, 94, 743-51 (2004)) (Pubitemid 38451735)
156. Rossig, L., C. Urbich, T. Bruhl, E. Dernbach, C. Heeschen, E. Chavakis, K. Sasaki, D. Aicher, F. Diehl, F. Seeger, M. Potente, A. Aicher, L. Zanetta, E. Dejana, A. M. Zeiher & S. Dimmeler: Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med, 201, 1825-35 (2005)) (Pubitemid 41002901)
157. Myers, C., A. Charboneau & N. Boudreau: Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol, 148, 343-51 (2000)) (Pubitemid 30078246)
158. Boudreau, N., C. Andrews, A. Srebrow, A. Ravanpay & D. A. Cheresh: Induction of the angiogenic phenotype by Hox D3. J Cell Biol, 139, 257-64 (1997)) (Pubitemid 27444096)
159. Winnik, S., M. Klinkert, H. Kurz, C. Zoeller, J. Heinke, Y. Wu, C. Bode, C. Patterson & M. Moser: HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving Angiopoietin-2. Cardiovasc Res (2009))
160. Petrova, T. V., T. Makinen, T. P. Makela, J. Saarela, I. Virtanen, R. E. Ferrell, D. N. Finegold, D. Kerjaschki, S. Yla-Herttuala & K. Alitalo: Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. Embo J, 21, 4593-9 (2002))
161. Wigle, J. T. & G. Oliver: Prox1 function is required for the development of the murine lymphatic system. Cell, 98, 769-78 (1999)) (Pubitemid 29446894)
162. Sanchez-Elsner, T., L. M. Botella, B. Velasco, A. Corbi, L. Attisano & C. Bernabeu: Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem, 276, 38527-35 (2001))
163. Hamik, A., B. Wang & M. K. Jain: Transcriptional regulators of angiogenesis. Arterioscler Thromb Vasc Biol, 26, 1936-47 (2006)) (Pubitemid 44253774)
164. Benezra, R., S. Rafii & D. Lyden: The Id proteins and angiogenesis. Oncogene, 20, 8334-41 (2001)) (Pubitemid 34121904)
165. Lee, J. S., Q. Yu, J. T. Shin, E. Sebzda, C. Bertozzi, M. Chen, P. Mericko, M. Stadtfeld, D. Zhou, L. Cheng, T. Graf, C. A. MacRae, J. J. Lepore, C. W. Lo & M. L. Kahn: Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell, 11, 845-57 (2006)) (Pubitemid 44804271)
166. Meadows, S. M., M. C. Salanga & P. A. Krieg: Kruppel-like factor 2 cooperates with the ETS family protein ERG to activate Flk1 expression during vascular development. Development (2009))
167. Lewis, B. P., C. B. Burge & D. P. Bartel: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20 (2005)) (Pubitemid 40094598)
168. Kuehbacher, A., C. Urbich, A. M. Zeiher & S. Dimmeler: Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res, 101, 59-68 (2007)) (Pubitemid 47094624)
169. Suarez, Y., C. Fernandez-Hernando, J. S. Pober & W. C. Sessa: Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res, 100, 1164-73 (2007)) (Pubitemid 46684129)
170. Yang, W. J., D. D. Yang, S. Na, G. E. Sandusky, Q. Zhang & G. Zhao: Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem, 280, 9330-5 (2005))
171. Fish, J. E., M. M. Santoro, S. U. Morton, S. Yu, R. F. Yeh, J. D. Wythe, K. N. Ivey, B. G. Bruneau, D. Y. Stainier & D. Srivastava: miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell, 15, 272-84 (2008))
172. Wang, S., A. B. Aurora, B. A. Johnson, X. Qi, J. McAnally, J. A. Hill, J. A. Richardson, R. Bassel-Duby & E. N. Olson: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell, 15, 261-71 (2008))
173. Nicoli, S., C. Standley, P. Walker, A. Hurlstone, K. E. Fogarty & N. D. Lawson: MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature, 464, 1196-200 (2010))
174. Torres-Vazquez, J., M. Kamei & B. M. Weinstein: Molecular distinction between arteries and veins. Cell Tissue Res, 314, 43-59 (2003)) (Pubitemid 37409912)
175. Aitsebaomo, J., A. L. Portbury, J. C. Schisler & C. Patterson: Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circ Res, 103, 929-39 (2008))
176. Pola, R., L. E. Ling, M. Silver, M. J. Corbley, M. Kearney, R. Blake Pepinsky, R. Shapiro, F. R. Taylor, D. P. Baker, T. Asahara & J. M. Isner: The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med, 7, 706-11 (2001)) (Pubitemid 32588027)
177. Williams, C. K., J. L. Li, M. Murga, A. L. Harris & G. Tosato: Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood, 107, 931-9 (2006)) (Pubitemid 43156289)
178. Hofmann, J. J. & M. L. Iruela-Arispe: Notch signaling in blood vessels: who is talking to whom about what? Circ Res, 100, 1556-68 (2007)) (Pubitemid 46897259)
179. Hutchins, G. M., A. Kessler-Hanna & G. W. Moore: Development of the coronary arteries in the embryonic human heart. Circulation, 77, 1250-7 (1988))
180. Mikawa, T. & R. G. Gourdie: Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol, 174, 221-32 (1996)) (Pubitemid 26132683)
181. Manner, J.: Does the subepicardial mesenchyme contribute myocardioblasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of the epicardial primordium. Anat Rec, 255, 212-26 (1999)) (Pubitemid 29249870)
182. Cai, C. L., J. C. Martin, Y. Sun, L. Cui, L. Wang, K. Ouyang, L. Yang, L. Bu, X. Liang, X. Zhang, W. B. Stallcup, C. P. Denton, A. McCulloch, J. Chen & S. M. Evans: A myocardial lineage derives from Tbx18 epicardial cells. Nature, 454, 104-8 (2008)) (Pubitemid 351931969)
183. Zhou, B., Q. Ma, S. Rajagopal, S. M. Wu, I. Domian, J. Rivera-Feliciano, D. Jiang, A. von Gise, S. Ikeda, K. R. Chien & W. T. Pu: Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 454, 109-13 (2008)) (Pubitemid 351931979)
184. Red-Horse, K., H. Ueno, I. L. Weissman & M. A. Krasnow: Coronary arteries form by developmental reprogramming of venous cells. Nature, 464, 549-53 (2010))
185. Francois, M., A. Caprini, B. Hosking, F. Orsenigo, D. Wilhelm, C. Browne, K. Paavonen, T. Karnezis, R. Shayan, M. Downes, T. Davidson, D. Tutt, K. S. Cheah, S. A. Stacker, G. E. Muscat, M. G. Achen, E. Dejana & P. Koopman: Sox18 induces development of the lymphatic vasculature in mice. Nature, 456, 643-7 (2008))
186. Carmeliet, P., Y. S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, I. Cornelissen, E. Ehler, V. V. Kakkar, I. Stalmans, V. Mattot, J. C. Perriard, M. Dewerchin, W. Flameng, A. Nagy, F. Lupu, L. Moons, D. Collen, P. A. D'Amore & D. T. Shima: Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med, 5, 495-502 (1999)) (Pubitemid 29220207)
187. Bellomo, D., J. P. Headrick, G. U. Silins, C. A. Paterson, P. S. Thomas, M. Gartside, A. Mould, M. M. Cahill, I. D. Tonks, S. M. Grimmond, S. Townson, C. Wells, M. Little, M. C. Cummings, N. K. Hayward & G. F. Kay: Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res, 86, E29-35 (2000))
188. Aase, K., G. von Euler, X. Li, A. Ponten, P. Thoren, R. Cao, Y. Cao, B. Olofsson, S. Gebre-Medhin, M. Pekny, K. Alitalo, C. Betsholtz & U. Eriksson: Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation, 104, 358-64 (2001)) (Pubitemid 32666961)
189. Carmeliet, P., L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. De Mol, Y. Wu, F. Bono, L. Devy, H. Beck, D. Scholz, T. Acker, T. DiPalma, M. Dewerchin, A. Noel, I. Stalmans, A. Barra, S. Blacher, T. Vandendriessche, A. Ponten, U. Eriksson, K. H. Plate, J. M. Foidart, W. Schaper, D. S. Charnock-Jones, D. J. Hicklin, J. M. Herbert, D. Collen & M. G. Persico: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med, 7, 575-83 (2001)) (Pubitemid 32448325)
190. Luttun, A., K. Brusselmans, H. Fukao, M. Tjwa, S. Ueshima, J. M. Herbert, O. Matsuo, D. Collen, P. Carmeliet & L. Moons: Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun, 295, 428-34 (2002)) (Pubitemid 34785852)
191. Xue, Y., X. Gao, C. E. Lindsell, C. R. Norton, B. Chang, C. Hicks, M. Gendron-Maguire, E. B. Rand, G. Weinmaster & T. Gridley: Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet, 8, 723-30 (1999)) (Pubitemid 29189039)
192. Gale, N. W., M. G. Dominguez, I. Noguera, L. Pan, V. Hughes, D. M. Valenzuela, A. J. Murphy, N. C. Adams, H. C. Lin, J. Holash, G. Thurston & G. D. Yancopoulos: Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A, 101, 15949-54 (2004))
193. Krebs, L. T., J. R. Shutter, K. Tanigaki, T. Honjo, K. L. Stark & T. Gridley: Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev, 18, 2469-73 (2004)) (Pubitemid 39362888)
194. Krebs, L. T., Y. Xue, C. R. Norton, J. R. Shutter, M. Maguire, J. P. Sundberg, D. Gallahan, V. Closson, J. Kitajewski, R. Callahan, G. H. Smith, K. L. Stark & T. Gridley: Notch signaling is essential for vascular morphogenesis in mice. Genes Dev, 14, 1343-52 (2000)) (Pubitemid 30397078)
195. Limbourg, F. P., K. Takeshita, F. Radtke, R. T. Bronson, M. T. Chin & J. K. Liao: Essential role of endothelial Notch1 in angiogenesis. Circulation, 111, 1826-32 (2005)) (Pubitemid 40525149)
196. Fischer, A., N. Schumacher, M. Maier, M. Sendtner & M. Gessler: The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev, 18, 901-11 (2004)) (Pubitemid 38529659)
197. Kokubo, H., S. Miyagawa-Tomita, M. Nakazawa, Y. Saga & R. L. Johnson: Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol, 278, 301-9 (2005)) (Pubitemid 40175030)
198. Zhou, M., R. L. Sutliff, R. J. Paul, J. N. Lorenz, J. B. Hoying, C. C. Haudenschild, M. Yin, J. D. Coffin, L. Kong, E. G. Kranias, W. Luo, G. P. Boivin, J. J. Duffy, S. A. Pawlowski & T. Doetschman: Fibroblast growth factor 2 control of vascular tone. Nat Med, 4, 201-7 (1998)) (Pubitemid 28137375)
199. Deng, C. X., A. Wynshaw-Boris, M. M. Shen, C. Daugherty, D. M. Ornitz & P. Leder: Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev, 8, 3045-57 (1994))
200. Sanford, L. P., I. Ormsby, A. C. Gittenberger-de Groot, H. Sariola, R. Friedman, G. P. Boivin, E. L. Cardell & T. Doetschman: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development, 124, 2659-70 (1997)) (Pubitemid 27341765)
201. Zhang, H. & A. Bradley: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development, 122, 2977-86 (1996)) (Pubitemid 26371964)
202. Larsson, J., M. J. Goumans, L. J. Sjostrand, M. A. van Rooijen, D. Ward, P. Leveen, X. Xu, P. ten Dijke, C. L. Mummery & S. Karlsson: Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. Embo J, 20, 1663-73 (2001)) (Pubitemid 32299403)
203. Oshima, M., H. Oshima & M. M. Taketo: TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol, 179, 297-302 (1996)) (Pubitemid 26363265)
204. Urness, L. D., L. K. Sorensen & D. Y. Li: Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet, 26, 328-31 (2000))
205. Bourdeau, A., D. J. Dumont & M. Letarte: A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest, 104, 1343-51 (1999))
206. Li, D. Y., L. K. Sorensen, B. S. Brooke, L. D. Urness, E. C. Davis, D. G. Taylor, B. B. Boak & D. P. Wendel: Defective angiogenesis in mice lacking endoglin. Science, 284, 1534-7 (1999))
207. Arthur, H. M., J. Ure, A. J. Smith, G. Renforth, D. I. Wilson, E. Torsney, R. Charlton, D. V. Parums, T. Jowett, D. A. Marchuk, J. Burn & A. G. Diamond: Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol, 217, 42-53 (2000)) (Pubitemid 30046798)
208. Sorensen, L. K., B. S. Brooke, D. Y. Li & L. D. Urness: Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol, 261, 235-50 (2003)) (Pubitemid 36993829)
209. Liu, D., J. Wang, B. Kinzel, M. Mueller, X. Mao, R. Valdez, Y. Liu & E. Li: Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood, 110, 1502-10 (2007)) (Pubitemid 47443965)
210. Beppu, H., F. Ichinose, N. Kawai, R. C. Jones, P. B. Yu, W. M. Zapol, K. Miyazono, E. Li & K. D. Bloch: BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol, 287, L1241-7 (2004)) (Pubitemid 39507203)
211. Yang, X., C. Li, X. Xu & C. Deng: The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A, 95, 3667-72 (1998)) (Pubitemid 28173185)
212. Sirard, C., J. L. de la Pompa, A. Elia, A. Itie, C. Mirtsos, A. Cheung, S. Hahn, A. Wakeham, L. Schwartz, S. E. Kern, J. Rossant & T. W. Mak: The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev, 12, 107-19 (1998)) (Pubitemid 28083662)
213. Byrd, N., S. Becker, P. Maye, R. Narasimhaiah, B. St-Jacques, X. Zhang, J. McMahon, A. McMahon & L. Grabel: Hedgehog is required for murine yolk sac angiogenesis. Development, 129, 361-72 (2002)) (Pubitemid 34863803)
214. Pepicelli, C. V., P. M. Lewis & A. P. McMahon: Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol, 8, 1083-6 (1998))
215. Zhang, X. M., M. Ramalho-Santos & A. P. McMahon: Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node. Cell, 105, 781-92 (2001)) (Pubitemid 32635107)
216. Adams, R. H., G. A. Wilkinson, C. Weiss, F. Diella, N. W. Gale, U. Deutsch, W. Risau & R. Klein: Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev, 13, 295-306 (1999)) (Pubitemid 29095801)
217. Gerety, S. S. & D. J. Anderson: Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development, 129, 1397-410 (2002)) (Pubitemid 34874161)
218. Kawasaki, T., T. Kitsukawa, Y. Bekku, Y. Matsuda, M. Sanbo, T. Yagi & H. Fujisawa: A requirement for neuropilin-1 in embryonic vessel formation. Development, 126, 4895-902 (1999))
219. Gerhardt, H., C. Ruhrberg, A. Abramsson, H. Fujisawa, D. Shima & C. Betsholtz: Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn, 231, 503-9 (2004)) (Pubitemid 39410884)
220. Gu, C., E. R. Rodriguez, D. V. Reimert, T. Shu, B. Fritzsch, L. J. Richards, A. L. Kolodkin & D. D. Ginty: Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell, 5, 45-57 (2003)) (Pubitemid 36827341)
221. Yuan, L., D. Moyon, L. Pardanaud, C. Breant, M. J. Karkkainen, K. Alitalo & A. Eichmann: Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development, 129, 4797-806 (2002)) (Pubitemid 35282411)
222. Behar, O., J. A. Golden, H. Mashimo, F. J. Schoen & M. C. Fishman: Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature, 383, 525-8 (1996)) (Pubitemid 26346178)
223. Serini, G., D. Valdembri, S. Zanivan, G. Morterra, C. Burkhardt, F. Caccavari, L. Zammataro, L. Primo, L. Tamagnone, M. Logan, M. Tessier-Lavigne, M. Taniguchi, A. W. Puschel & F. Bussolino: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature, 424, 391-7 (2003)) (Pubitemid 36917481)
224. Fiore, R., B. Rahim, V. M. Christoffels, A. F. Moorman & A. W. Puschel: Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system. Mol Cell Biol, 25, 2310-9 (2005))
225. Gu, C., Y. Yoshida, J. Livet, D. V. Reimert, F. Mann, J. Merte, C. E. Henderson, T. M. Jessell, A. L. Kolodkin & D. D. Ginty: Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science, 307, 265-8 (2005)) (Pubitemid 40116243)
226. Lu, X., F. Le Noble, L. Yuan, Q. Jiang, B. De Lafarge, D. Sugiyama, C. Breant, F. Claes, F. De Smet, J. L. Thomas, M. Autiero, P. Carmeliet, M. Tessier-Lavigne & A. Eichmann: The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature, 432, 179-86 (2004)) (Pubitemid 39545842)
227. Navankasattusas, S., K. J. Whitehead, A. Suli, L. K. Sorensen, A. H. Lim, J. Zhao, K. W. Park, J. D. Wythe, K. R. Thomas, C. B. Chien & D. Y. Li: The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development, 135, 659-67 (2008)) (Pubitemid 351405019)
228. Robb, L., I. Lyons, R. Li, L. Hartley, F. Kontgen, R. P. Harvey, D. Metcalf & C. G. Begley: Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A, 92, 7075-9 (1995))
229. Shivdasani, R. A., E. L. Mayer & S. H. Orkin: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature, 373, 432-4 (1995))
230. Furuyama, T., K. Kitayama, Y. Shimoda, M. Ogawa, K. Sone, K. Yoshida-Araki, H. Hisatsune, S. Nishikawa, K. Nakayama, K. Nakayama, K. Ikeda, N. Motoyama & N. Mori: Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem, 279, 34741-9 (2004))
231. Spyropoulos, D. D., P. N. Pharr, K. R. Lavenburg, P. Jackers, T. S. Papas, M. Ogawa & D. K. Watson: Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol, 20, 5643-52 (2000)) (Pubitemid 30482898)
232. Ryan, H. E., J. Lo & R. S. Johnson: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J, 17, 3005-15 (1998)) (Pubitemid 28254373)
233. Iyer, N. V., L. E. Kotch, F. Agani, S. W. Leung, E. Laughner, R. H. Wenger, M. Gassmann, J. D. Gearhart, A. M. Lawler, A. Y. Yu & G. L. Semenza: Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 12, 149-62 (1998)) (Pubitemid 28060446)
234. Peng, J., L. Zhang, L. Drysdale & G. H. Fong: The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci U S A, 97, 8386-91 (2000)) (Pubitemid 30639682)
235. Maltepe, E., J. V. Schmidt, D. Baunoch, C. A. Bradfield & M. C. Simon: Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386, 403-7 (1997)) (Pubitemid 27154481)
236. Lyden, D., A. Z. Young, D. Zagzag, W. Yan, W. Gerald, R. O'Reilly, B. L. Bader, R. O. Hynes, Y. Zhuang, K. Manova & R. Benezra: Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670-7 (1999))
237. Baudino, T. A., C. McKay, H. Pendeville-Samain, J. A. Nilsson, K. H. Maclean, E. L. White, A. C. Davis, J. N. Ihle & J. L. Cleveland: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev, 16, 2530-43 (2002))
238. Pereira, F. A., Y. Qiu, G. Zhou, M. J. Tsai & S. Y. Tsai: The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev, 13, 1037-49 (1999)) (Pubitemid 29200986)
239. You, L. R., F. J. Lin, C. T. Lee, F. J. DeMayo, M. J. Tsai & S. Y. Tsai: Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature, 435, 98-104 (2005)) (Pubitemid 40655915)